Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease.
Matthews DC, Mao X, Dowd K, Tsakanikas D, Jiang CS, Meuser C, Andrews RD, Lukic AS, Lee J, Hampilos N, Shafiian N, Sano M, David Mozley P, Fillit H, McEwen BS, Shungu DC, Pereira AC.
Matthews DC, et al. Among authors: mcewen bs.
Brain. 2021 Dec 31;144(12):3742-3755. doi: 10.1093/brain/awab222.
Brain. 2021.
PMID: 34145880
Free PMC article.
Clinical Trial.